RxDoctor Payments Data

Visnja Novacki, MD

Psychiatry · Reston, VANPI 1649381773

Payments from drug & device makers

$2,182in general payments, 2019–2025

Across 101 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$487
  • Teva Pharmaceuticals USA, Inc.$446
  • Neurocrine Biosciences, Inc.$269
  • Johnson & Johnson$206
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$204
  • Otsuka America Pharmaceutical, Inc.$202
  • plus $368 from 2 others

What the payments were for

  • Food & beverage$2,08295%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,182 in reported general payments places this provider in the 80th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$24,395
Medicare patients
41
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Risperdal ConstaRisperidone Microspheres36$79,476
Abilify MaintenaAripiprazole12$33,085
Invega SustennaPaliperidone Palmitate18$30,923
Clozapine98$6,848
Aripiprazole52$3,827
Paliperidone ErPaliperidone23$3,106
Lurasidone Hcl26$2,946
Quetiapine Fumarate110$1,937
Olanzapine77$1,215
Clonazepam124$880
Risperidone100$822
Duloxetine Hcl71$615
Benztropine Mesylate55$594
Divalproex Sodium ErDivalproex Sodium20$594
Haloperidol24$574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonRisperdal Consta, Invega Sustenna$206$110,40054 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$202$33,08512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Reston

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →